Single answer
Is Abeona Therapeutics Inc (ABEO) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Abeona Therapeutics Inc is $14.00, which is $8.81 (169.75%) above the current price today's price.
Low target: $6.00 | High target: $20.00
Company snapshot
A quick overview of the business and its public profile.
Abeona Therapeutics Inc a clinicalstage biopharmaceutical company develops gene and cell therapies for lifethreatening rare genetic diseases Its lead program is EB101 an autologous genecorrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa The company also develops ABO102 an adenoassociated virus AAVbased gene therapy for Sanfilippo syndrome type A ABO201 to treat CLN3 disease ABO401 for the treatment of cystic fibrosis and ABO50X for the treatment of genetic eye disorders In addition it is developing AAVbased gene therapy through its AIM vector platform programs The company was formerly known as PlasmaTech Biopharmaceuticals Inc and changed its name to Abeona Therapeutics Inc in June 2015 Abeona Therapeutics Inc was incorporated in 1974 and is headquartered in New York New York
Website: https://www.abeonatherapeutics.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.10. Cash flow to debt ratio: -3.11. Net profit margin: 1,589.15%. Inflation risk score: low (0.45/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Abeona Therapeutics Inc is $7.3M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Abeona Therapeutics Inc, 2015-12-31 had a stock price of $84.00. If you invested back then, your return now would be a loss of $78.82 per share or 93.83%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.